Slide 1: Fourth quarter
Fourth quarter CEO Christer Wahlquist CFO Per-Ola Holmström February 7, 2025 1
Slide 2: Q4 summary – Nolato Group
Q4 summary – Nolato Group A global solutions provider established on three continents ● Sales increased to SEK 2,382 million (2,252) - An increase of 5% adjusted for currency SEKm 12000 - Organic growth for both business areas 11000 ● Operating profit (EBITA) rose by 36% to SEK 240 million (177) 100
Slide 3: Full year 2024 in brief – Nolato Group
Full year 2024 in brief – Nolato Group ● Sales totaled SEK 9,664 million (9,546) A global solutions provider established on three continents - Increase of 1% adjusted for currency MSEK ● Operating profit (EBITA) rose to SEK 958 million (761, excl. non- 12000 recurring item in 2023) 11000 ● EBITA mar
Slide 4: One Group – two business areas
One Group – two business areas Nolato Medical Solutions Engineered Solutions Our offering as a strategic partner for selected Development and manufacture of complex Design, development, industrialization and global customers comprises development and product systems and components for medical manufa
Slide 5: Medical Solutions – sustainable growth and global expansion
Medical Solutions – sustainable growth and global expansion SEKm 5500 5000 4500 4000 3500 3000 1,359 152 2500 2000 SALES EBITA-RESULT SEKm, Q4 SEKm, Q4 1500 11.2 1000 57 EBITA-MARGIN 500 SHARE OF THE GROUP 0 %, Q4 %, Q4 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 5 5
Slide 6: Medical Solutions – focused product areas
Medical Solutions – focused product areas Pharma Diagnostics Medical Devices Drug Delivery In-vitro-diagnostics (IVD) Endoscopy & General Surgery Cardiology Continence care Pharma Packaging Other 6
Slide 7: Medical Solutions – Q4
Medical Solutions – Q4 ● 5% increase in sales Q4 Full year - An increase of 4% adjusted for currency SEKm 2024 2023 2024 2023 - The Drug Delivery market area showed strong growth - IVD grew compared with a weak quarter last year Sales 1,359 1,300 5,434 5,308 - Pharmaceutical Packaging had lower volu
Slide 8: Engineered Solutions – advanced technology and high-productivity manufacturing
Engineered Solutions – advanced technology and high-productivity manufacturing SEKm 8000 7500 7000 6500 6000 5500 5000 4500 4000 1,033 95 3500 3000 2500 SALES EBITA-RESULT SEKm, Q4 SEKm, Q4 2000 1500 43 9.2 1000 500 SHARE OF THE GROUP EBITA-MARGIN 0 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21
Slide 9: Engineered Solutions – focused product areas
Engineered Solutions – focused product areas Materials Consumer electronics Automotive Other Hygiene 9
Slide 10: Engineered Solutions – Q4
Engineered Solutions – Q4 ● 8% increase in sales - A sharp increase of 7%, adjusted for currency Q4 Full year - All market areas except Automotive showed increased sales SEKm 2024 2023 2024 2023 - Consumer electronics experienced increased growth from low levels; investments in new areas are bearing
Slide 11: Group financial highlights Key performance indicators
Group financial highlights Q4 Full year SEKm 2024 2023 2024 2023 Net sales 2,382 2,252 9,664 9,546 Operating profit (EBITA)* 240 177 958 701 Operating profit (EBITA), excl. non-recurring item in 2023 240 177 958 761 EBITA margin (%), excl. non-recurring item in 2023 10.1 7.9 9.9 8.0 Profit after fin
Slide 12: Current situation
Current situation Medical Solutions Engineered Solutions • Maintained growth strategy • VHP effects phased out from Q3 2024 • Focus on margin – cost adjustments, pricing strategy and • Advanced market positions efficiency • Established position in new product areas • Innovation and sustainability •
Slide 13: An update on Nolato's future Capital Markets Day
An update on Nolato's future Nolato invites investors, analysts, and media to a Capital Markets Day for insights into strategy, market position, and financial outlook. The management team will deliver presentations followed by interactive Q&A sessions. Date and Time: The Capital Markets Day will tak
Slide 14: Thank you.
Thank you. This presentation may contain forward-looking statements. When used in this presentation, words such as “anticipate”, “believe”, “estimate”, “expect”, “plan” and “project” are intended to identify forward-looking statements. Such statements could encompass risks and uncertainties pertaini